CNR2 and cancer: Furthermore, this CB2 agonist reduced the biological processes of proliferation and migration of cancerous cells, also with a more evident effect on highly metastatic cells, suggesting that the greater drug-induced CB2R nucleolar removal could be linked with a more anti-cancer action of HU-308.